| Effectiveness of seasonal 2008–2009, 2009–2010 and pandemic vaccines, to prevent influenza hospitalizations during the autumn 2009 influenza pandemic wave in Castellón, Spain … J Puig-Barberà, A Arnedo-Pena, F Pardo-Serrano, MD Tirado-Balaguer, ... Vaccine 28 (47), 7460-7467, 2010 | 111 | 2010 |
| Population-based analysis of bronchiolitis epidemiology in Valencia, Spain C Muñoz-Quiles, M López-Lacort, I Úbeda-Sansano, S Alemán-Sánchez, ... The Pediatric infectious disease journal 35 (3), 275-280, 2016 | 84 | 2016 |
| Narcolepsy and adjuvanted pandemic influenza A (H1N1) 2009 vaccines–Multi-country assessment D Weibel, M Sturkenboom, S Black, M de Ridder, C Dodd, J Bonhoeffer, ... Vaccine 36 (41), 6202-6211, 2018 | 71 | 2018 |
| Progress in vaccination towards hepatitis B control and elimination in the Region of the Americas AM Ropero Álvarez, S Pérez-Vilar, C Pacis-Tirso, M Contreras, ... BMC Public Health 17, 1-10, 2017 | 61 | 2017 |
| Effectiveness of the 2010–2011 seasonal influenza vaccine in preventing confirmed influenza hospitalizations in adults: A case–case comparison, case-control study J Puig-Barbera, J Diez-Domingo, A Arnedo-Pena, M Ruiz-Garcia, ... Vaccine 30 (39), 5714-5720, 2012 | 59 | 2012 |
| Bias due to differential and non-differential disease-and exposure misclassification in studies of vaccine effectiveness T De Smedt, E Merrall, D Macina, S Perez-Vilar, N Andrews, K Bollaerts PLoS One 13 (6), e0199180, 2018 | 57 | 2018 |
| Association of COVID-19 vs influenza with risk of arterial and venous thrombotic events among hospitalized patients VL Re, SK Dutcher, JG Connolly, S Perez-Vilar, DM Carbonari, TA DeFor, ... Jama 328 (7), 637-651, 2022 | 40 | 2022 |
| Erythema multiforme, Stevens Johnson syndrome, and toxic epidermal necrolysis reported after vaccination, 1999–2017 JR Su, P Haber, CS Ng, PL Marquez, GM Dores, S Perez-Vilar, MV Cano Vaccine 38 (7), 1746-1752, 2020 | 38 | 2020 |
| Enhancing global vaccine pharmacovigilance: proof-of-concept study on aseptic meningitis and immune thrombocytopenic purpura following measles-mumps containing vaccination S Perez-Vilar, D Weibel, M Sturkenboom, S Black, C Maure, JL Castro, ... Vaccine 36 (3), 347-354, 2018 | 38 | 2018 |
| Adverse events associated with the use of sipuleucel-T reported to the US Food and Drug Administration’s Adverse Event Reporting System, 2010-2017 GM Dores, M Bryant-Genevier, S Perez-Vilar JAMA Network Open 2 (8), e199249-e199249, 2019 | 36 | 2019 |
| Effectiveness of rotavirus vaccines, licensed but not funded, against rotavirus hospitalizations in the Valencia Region, Spain S Pérez-Vilar, J Díez-Domingo, M López-Lacort, S Martínez-Úbeda, ... BMC infectious diseases 15, 1-9, 2015 | 36 | 2015 |
| Long-term impact of self-financed rotavirus vaccines on rotavirus-associated hospitalizations and costs in the Valencia Region, Spain A Orrico-Sanchez, M López-Lacort, S Pérez-Vilar, J Díez-Domingo BMC Infectious Diseases 17, 1-8, 2017 | 28 | 2017 |
| Vaccine safety surveillance in pregnancy in low-and middle-income countries using GAIA case definitions: A feasibility assessment AL Stuurman, M Riera, S Lamprianou, S Perez-Vilar, SA Anderson, ... Vaccine 36 (45), 6736-6743, 2018 | 25 | 2018 |
| MF59-adjuvanted and virosomal influenza vaccines for preventing influenza hospitalization in older people: comparative effectiveness using the Valencia health care information … J Puig-Barberà, A Natividad-Sancho, J Calabuig-Pérez, JA Lluch-Rodrigo, ... Vaccine 31 (37), 3995-4002, 2013 | 25 | 2013 |
| A COVID‐19‐ready public health surveillance system: the Food and Drug Administration's sentinel system NM Cocoros, CC Fuller, S Adimadhyam, R Ball, JS Brown, GJ Dal Pan, ... Pharmacoepidemiology and Drug Safety 30 (7), 827-837, 2021 | 24 | 2021 |
| Intussusception following rotavirus vaccination in the Valencia Region, Spain S Pérez-Vilar, J Díez-Domingo, J Puig-Barberà, R Gil-Prieto, S Romio Human Vaccines & Immunotherapeutics 11 (7), 1848-1852, 2015 | 24 | 2015 |
| Incidence rates of narcolepsy diagnoses in Taiwan, Canada, and Europe: The use of statistical simulation to evaluate methods for the rapid assessment of potential safety issues … CN Dodd, M De Ridder, WT Huang, D Weibel, M Giner-Soriano, ... PloS one 13 (10), e0204799, 2018 | 22 | 2018 |
| Influenza vaccine effectiveness in preventing influenza A (H3N2)-related hospitalizations in adults targeted for vaccination by type of vaccine: a hospital-based test-negative … J Puig-Barberà, J García-de-Lomas, J Díez-Domingo, A Arnedo-Pena, ... PloS one 9 (11), e112294, 2014 | 22 | 2014 |
| Guillain-Barré syndrome after high-dose influenza vaccine administration in the United States, 2018–2019 season S Perez-Vilar, M Hu, E Weintraub, D Arya, B Lufkin, T Myers, EJ Woo, ... The Journal of infectious diseases 223 (3), 416-425, 2021 | 21 | 2021 |
| Systemic corticosteroid use for COVID-19 in US outpatient settings from April 2020 to August 2021 MC Bradley, S Perez-Vilar, Y Chillarige, D Dong, AI Martinez, ... Jama 327 (20), 2015-2018, 2022 | 20 | 2022 |
